CompletedNot Applicable

Oxygen Supplementation Study in Obstructive Sleep Apnea (OSA) Patients

Canada196 participantsStarted 2012-02

Plain-language summary

Hypotheses: 1. Postoperative oxygen therapy significantly improves postoperative oxygenation in OSA surgical patients. 2. Postoperative oxygen therapy do not significantly increase the number of apnea episodes and the duration of apnea episodes. 3. Postoperative oxygen therapy do not significantly increase arterial carbon dioxide(CO2) level in OSA surgical patients.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who are scheduled for inpatient surgery that requires a minimum of three nights of hospital stay * Age: 18 to 80 years old. * Identified as high risk of having OSA or diagnosed with OSA but not using CPAP. Exclusion Criteria: * Undergoing nasal, eye, head/neck surgery, intracranial or cardiac/thoracic surgery. * Unwilling or unable to give informed consent. * Requiring prolonged postoperative ventilation. * Having chronic obstructive pulmonary disease, * HCO3 ≥30. * Visiting preoperative clinic \< 1day before scheduled surgical date. * Having tracheotomy, facial, neck, or chest wall abnormalities. * Currently receiving treatment for sleep apnea including CPAP.

What they're measuring

Pulse oxygen saturation

Timeframe: 3 nights postoperatively

Sleep disordered breathing

Timeframe: Postoperative night 3 only

Blood CO2 level

Timeframe: postoperative night1 to noght 3

Trial details

NCT IDNCT01552304

SponsorUniversity Health Network, Toronto

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-04

View on ClinicalTrials.gov More Obstructive Sleep Apnea trials